Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,020.00    -52.00 (-2.51%)
Bid:
2,008.00
Ask:
2,016.00
Spread: 8.00 (0.398%)
Market Cap: £1.34b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

24 Feb 2023 17:13

RNS Number : 0490R
Genus PLC
24 February 2023
Β 

24 February 2023

Β 

Genus plc

Β 

Director/PDMR Shareholding

Β 

Genus plc (LSE: GNS) has been notified that Per Henriksen, the husband of Alison Henriksen, Chief Financial Officer, purchased:

Β· 1,658 ordinary shares in the Company on 23 February 2023 on the London Stock Exchange at an average price of 2,999.28 pence per share, listed in Table A below; and

Β· 1,718 ordinary shares in the Company on 24 February 2023 on the London Stock Exchange at an average price of 2,895.14 pence per share, listed in Table B below.

Β 

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of ordinary shares purchased.

Β 

Β 

For further information please contact:

Β 

Genus:

Dan Hartley, Group General Counsel and Company Secretary Tel: +44 (0)1256 347100

Β 

Table A - GELT Private Share Purchase

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Per Henriksen

2.

Reason for the notification

a.

Position/status

This notification concerns a person closely associated with a person discharging managerial responsibilities being Alison Henriksen

b.

Initial notification

/Amendment

Β 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

Β 

Β 

GB0002074580

b.

Nature of the transaction

Purchase of 1,658 ordinary shares.

c.

Price(s) and volume(s)

Β 

Price(s)

Β 

Volume(s)

2,999.28p

1,658

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

Β 

Β 

Average price(s)

Β 

Total volume(s)

2,999.28p

1,658

e.

Date of the transaction

2023-02-23

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

Β 

Table B - GELT Private Share Purchase

Β 

5.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Per Henriksen

6.

Reason for the notification

a.

Position/status

This notification concerns a person closely associated with a person discharging managerial responsibilities being Alison Henriksen

b.

Initial notification

/Amendment

Β 

Initial notification

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

Β 

Β 

GB0002074580

b.

Nature of the transaction

Purchase of 1,718 ordinary shares.

c.

Price(s) and volume(s)

Β 

Price(s)

Β 

Volume(s)

2,895.14p

1,718

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

Β 

Β 

Average price(s)

Β 

Total volume(s)

2,895.14p

1,718

e.

Date of the transaction

2023-02-24

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUSABROUUUUAR
Date   Source Headline
8th Sep 20165:18 pmRNSDirector/PDMR Shareholding
8th Sep 20167:00 amRNSPreliminary Results
7th Sep 20167:00 amRNSNON-EXECUTIVE DIRECTOR RETIREMENT
1st Sep 20164:17 pmRNSTotal Voting Rights
15th Aug 20167:00 amRNSFINAL JURY DECISIONS IN US LITIGATION
12th Aug 20167:00 amRNSFURTHER DECISIONS IN US LITIGATION
11th Aug 20167:00 amRNSFIRST DECISIONS IN US ANTI-TRUST LITIGATION
1st Aug 20169:20 amRNSBlock listing Interim Review
1st Aug 20169:09 amRNSTotal Voting Rights
27th Jul 20167:00 amRNSSigns exclusive licence for tech. to combat BRD
15th Jul 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
1st Jul 20163:10 pmRNSTotal Voting Rights
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20162:00 pmRNSTotal Voting Rights
18th May 20167:00 amRNSExclusive Licence for Leading Gene Editing Tech
3rd May 20162:29 pmRNSTotal Voting Rights
13th Apr 20163:13 pmRNSDirector/PDMR Shareholding
1st Apr 20163:31 pmRNSDirector/PDMR Shareholding
9th Mar 20165:03 pmRNSDirector/PDMR Shareholding
4th Mar 20169:30 amRNSBOARD APPOINTMENT
3rd Mar 20162:00 pmRNSDirector/PDMR Shareholding
1st Mar 20165:17 pmRNSDirector/PDMR Shareholding
23rd Feb 20167:00 amRNSINTERIM RESULTS
1st Feb 20161:22 pmRNSBlocklisting Interim Review
4th Jan 20165:40 pmRNSTotal Voting Rights
11th Dec 20153:14 pmRNSDirector/PDMR Shareholding
9th Dec 20154:30 pmRNSDirector/PDMR Shareholding
8th Dec 20157:00 amRNSTackles major pig disease with breakthrough tech
1st Dec 20154:54 pmRNSHolding(s) in Company
1st Dec 20154:46 pmRNSTotal Voting Rights
19th Nov 20152:52 pmRNSResult of AGM
19th Nov 20157:00 amRNSAGM - TRADING UPDATE
2nd Nov 20153:04 pmRNSTotal Voting Rights
22nd Oct 20155:48 pmRNSHolding(s) in Company
21st Oct 20156:10 pmRNSDirector/PDMR Shareholding
15th Oct 201512:46 pmRNSAnnual Report and Notice of AGM
1st Oct 20153:00 pmRNSTotal Voting Rights
15th Sep 201511:00 amRNSDirector/PDMR Shareholding
8th Sep 20157:00 amRNSPreliminary Results
3rd Aug 20152:00 pmRNSBlocklisting Interim Review
30th Jun 20152:00 pmRNSTotal Voting Rights
29th Jun 20152:00 pmRNSChange of Registered Office
29th May 20152:00 pmRNSTotal Voting Rights
12th May 20157:00 amRNSCapital Markets Event and Trading Update
11th May 20152:00 pmRNSHolding(s) in Company
7th May 20152:21 pmRNSHolding(s) in Company
30th Apr 20152:00 pmRNSTotal Voting Rights
14th Apr 20152:00 pmRNSDirector/PDMR Shareholding
13th Apr 20155:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.